R. Degenring

Most-cited papers

1. Intravitreal injection of triamcinolone for diffuse diabetic macular edema.

   J. Jonas, I. Kreissig, Antje Söfker, R. Degenring

   2003A M A Archives of Ophthalmology589 citations Open access

   Semantic Scholar

   Save

2. Intraocular pressure after intravitreal injection of triamcinolone acetonide

   J. Jonas, I. Kreissig, R. Degenring

   2003British Journal of Ophthalmology439 citations Open access

   Semantic Scholar

   Save

3. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion

   J. Jonas, I. Kreissig, R. Degenring

   2002Graefe's Archive for Clinical and Experimental Ophthalmology229 citations

   Semantic Scholar

   Save

4. Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide.

   J. Jonas, I. Kreissig, R. Degenring

   2003A M A Archives of Ophthalmology220 citations

   Semantic Scholar

   Save

5. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.

   J. Jonas, R. Degenring, I. Kreissig, I. Akkoyun +1 more

   2005Ophthalmology (Rochester, Minn.)197 citations

   Semantic Scholar

   Save

6. Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide

   J. Jonas, I. Akkoyun, B. Kamppeter, I. Kreissig +1 more

   2005Eye169 citations

   Semantic Scholar

   Save

7. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.

   J. Jonas, I. Kreissig, R. Degenring

   2005Progress in retinal and eye research164 citations

   Semantic Scholar

   Save

8. Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema.

   J. Jonas, I. Kreissig, R. Degenring

   2003American journal of ophthalmology-glaucoma162 citations

   Semantic Scholar

   Save

9. Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration.

   J. Jonas, I. Akkoyun, W. Budde, I. Kreissig +1 more

   2004A M A Archives of Ophthalmology133 citations Open access

   Semantic Scholar

   Save

10. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.

    J. Jonas, R. Degenring, B. Kamppeter, I. Kreissig +1 more

    2004American journal of ophthalmology-glaucoma126 citations

    Semantic Scholar

    Save

11. Endophthalmitis after intravitreal injection of triamcinolone acetonide.

    J. Jonas, I. Kreissig, R. Degenring

    2003A M A Archives of Ophthalmology97 citations

    Semantic Scholar

    Save

12. Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study

    J. Jonas, R. Degenring, I. Kreissig, T. Friedemann +1 more

    2005Eye92 citations

    Semantic Scholar

    Save

13. Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study

    J. Jonas, I. Akkoyun, I. Kreissig, R. Degenring

    2005British Journal of Ophthalmology90 citations Open access

    Semantic Scholar

    Save

14. Choroidal neovascularisation secondary to Best’s disease in a 13-year-old boy treated by intravitreal bevacizumab

    J. Leu, N. Schrage, R. Degenring

    2007Graefe's Archive for Clinical and Experimental Ophthalmology82 citations

    Semantic Scholar

    Save

15. Predictive factors for visual acuity after intravitreal triamcinolone treatment for diabetic macular edema.

    J. Jonas, P. Martus, R. Degenring, I. Kreissig +1 more

    2005A M A Archives of Ophthalmology80 citations

    Semantic Scholar

    Save

16. Effect of uncomplicated phacoemulsification on the central retina in diabetic and non-diabetic subjects

    R. Degenring, S. Vey, B. Kamppeter, W. Budde +2 more

    2006Graefe's Archive for Clinical and Experimental Ophthalmology79 citations

    Semantic Scholar

    Save

17. Safety of intravitreal high-dose reinjections of triamcinolone acetonide.

    J. Jonas, R. Degenring, I. Kreissig, I. Akkoyun

    2004American journal of ophthalmology-glaucoma72 citations

    Semantic Scholar

    Save

18. Repeated intravitreal injections of triamcinolone acetonide as treatment of progressive exudative age-related macular degeneration

    J. Jonas, I. Kreissig, R. Degenring

    2002Graefe's Archive for Clinical and Experimental Ophthalmology69 citations

    Semantic Scholar

    Save

19. Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion.

    R. Degenring, B. Kamppeter, I. Kreissig, J. Jonas

    2003Acta ophthalmologica66 citations Open access

    Semantic Scholar

    Save

20. Intravitreal Triamcinolone Acetonide for Treatment of Central Retinal Vein Occlusion

    J. Jonas, I. Akkoyun, B. Kamppeter, I. Kreissig +1 more

    2005European Journal of Ophthalmology58 citations

    Semantic Scholar

    Save

21. Serum levels of triamcinolone acetonide after intravitreal injection.

    R. Degenring, J. Jonas

    2004American journal of ophthalmology-glaucoma57 citations

    Semantic Scholar

    Save

22. Intravitreal crystalline triamcinolone acetonide as an additional tool in pars plana vitrectomy for complicated proliferative vitreoretinopathy?

    J. Jonas, Antje Söfker, J. Hayler, R. Degenring

    2003Acta ophthalmologica42 citations

    Semantic Scholar

    Save

23. Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration

    J. Jonas, I. Kreissig, R. Degenring

    2004British Journal of Ophthalmology40 citations Open access

    Semantic Scholar

    Save

24. Cataract surgery after intravitreal injection of triamcinolone acetonide

    J. Jonas, I. Kreissig, R. Degenring

    2004Eye39 citations

    Semantic Scholar

    Save

25. Retinal complications of intravitreal injections of triamcinolone acetonide

    J. Jonas, I. Kreissig, R. Degenring

    2004Graefe's Archive for Clinical and Experimental Ophthalmology38 citations

    Semantic Scholar

    Save

26. Intravitreal Triamcinolone Acetonide as an Additional Tool in Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy

    J. Jonas, Antje Söfker, R. Degenring

    2003European Journal of Ophthalmology33 citations

    Semantic Scholar

    Save

27. Intravitreales Triamcinolonacetonid zur Behandlung intraokulärer ödematöser und neovaskulärer Erkrankungen

    J. Jonas, I. Kreissig, B. Kamppeter, R. Degenring

    2004Der Ophthalmologe32 citations

    Semantic Scholar

    Save

28. Neovascular glaucoma treated by intravitreal triamcinolone acetonide.

    J. Jonas, I. Kreissig, R. Degenring

    2003Acta ophthalmologica30 citations

    Semantic Scholar

    Save

29. Photodynamic therapy in combination with intravitreal triamcinolone for myopic choroidal neovascularization.

    R. Degenring, J. Jonas

    2005Acta ophthalmologica28 citations

    Semantic Scholar

    Save

30. Intravitreal Triamcinolone Acetonide as Treatment of Ischemic Ophthalmopathy

    J. Jonas, I. Kreissig, R. Degenring

    2003European Journal of Ophthalmology27 citations

    Semantic Scholar

    Save

31. Optical coherence tomography and confocal scanning laser tomography for assessment of macular edema.

    R. Degenring, I. Aschmoneit, B. Kamppeter, W. Budde +1 more

    2004American journal of ophthalmology-glaucoma26 citations

    Semantic Scholar

    Save

32. Cataract Surgery Combined with Intravitreal Injection of Triamcinolone Acetonide

    J. Jonas, I. Kreissig, W. Budde, R. Degenring

    2005European Journal of Ophthalmology25 citations

    Semantic Scholar

    Save

33. Optical Coherence Tomography of the Optic Nerve Head: Interindividual Reproducibility

    B. Kamppeter, K. Schubert, W. Budde, R. Degenring +1 more

    2006Journal of glaucoma22 citations

    Semantic Scholar

    Save

34. Autologous translocation of the retinal pigment epithelium and choroid in the treatment of neovascular age‐related macular degeneration

    R. Degenring, A. Cordes, N. Schrage

    2011Acta ophthalmologica16 citations Open access

    Semantic Scholar

    Save

35. Duration of the Effect of Intravitreal Triamcinolone Acetonide in Eyes with Exudative Age-Related Macular Degeneration

    J. Jonas, U. Spandau, B. Kamppeter, R. Degenring +3 more

    2006Journal of Ocular Pharmacology and Therapeutics16 citations

    Semantic Scholar

    Save

36. [Diffuse diabetic macular edema. Intraocular pressure after intravitreal triamcinolone acetonide].

    I. Kreissig, R. Degenring, J. Jonas

    2005Der Ophthalmologe15 citations

    Semantic Scholar

    Save

37. Outcome of eyes undergoing trabeculectomy after intravitreal injections of triamcinolone acetonide.

    J. Jonas, R. Degenring, B. Kamppeter

    2004Journal of glaucoma15 citations

    Semantic Scholar

    Save

38. [Intravitreal injection of crystalline triamcinolone acetonide in the treatment of diffuse diabetic macular oedema].

    J. Jonas, R. Degenring

    2002Klinische Monatsblätter für Augenheilkunde15 citations

    Semantic Scholar

    Save

39. Vitreous prolapse and IOL dislocation during intravitreal injection of triamcinolone acetonide

    R. Degenring, G. Sauder

    2006Graefe's Archive for Clinical and Experimental Ophthalmology13 citations

    Semantic Scholar

    Save

40. Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy.

    J. Jonas, A. Sfker, R. Degenring

    2003European Journal of Ophthalmology13 citations

    Semantic Scholar

    Save

41. Reply to intravitreal triamcinolone acetonide as treatment of branch retinal vein occlusion

    J. Jonas, I. Akkoyun, B. Kamppeter, I. Kreissig +1 more

    2006Eye9 citations

    Semantic Scholar

    Save

42. [Intraocular triamcinolone for diffuse diabetic macular edema].

    R. Degenring, I. Kreissig, J. Jonas

    2004Der Ophthalmologe9 citations

    Semantic Scholar

    Save

43. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].

    J. Jonas, I. Kreissig, R. Degenring

    2003Klinische Monatsblätter für Augenheilkunde8 citations

    Semantic Scholar

    Save

44. Readaptationszeit nach Photostress bei Normalpersonen und Glaukompatienten

    B. Kamppeter, R. Degenring, J. Jonas

    2003Der Ophthalmologe6 citations

    Semantic Scholar

    Save

45. Fluorescein Angiography after Intravitreal Injection of Triamcinolone Acetonide as Treatment of Diffuse Diabetic Macular Edema

    R. Degenring, I. Kreissig, J. Jonas

    20026 citations

    Semantic Scholar

    Save

46. [Transitory reduction of vision without metamorphopsia].

    R. Degenring, B. Kamppeter, G. Sauder, J. Jonas

    2004Der Ophthalmologe5 citations

    Semantic Scholar

    Save

47. [Grid laser photocoagulation in diffuse diabetic macular edema].

    R. Degenring, P. Hugger, G. Sauder, J. Jonas

    2004Klinische Monatsblätter für Augenheilkunde5 citations

    Semantic Scholar

    Save

48. Diffuses diabetisches Makulaödem

    I. Kreissig, R. Degenring, J. Jonas

    2005Der Ophthalmologe4 citations

    Semantic Scholar

    Save

49. Rinsing of the cannula prior to intravitreal injection.

    R. Degenring, J. Jonas

    2004A M A Archives of Ophthalmology3 citations

    Semantic Scholar

    Save

50. Phototoxic maculopathy after secondary intraocular lens implantation.

    G. Sauder, R. Degenring, M. Jaeger, Caroline Heyer +1 more

    2004Journal of cataract and refractive surgery3 citations

    Semantic Scholar

    Save